ABSTRACT
INTRODUCTION
Recent advances in reporter gene technology combined with significant developments in digital imaging microscopy now enable molecular processes such as gene expression to be visualized in living cells. Our laboratory has made good use of these technological advances to achieve dynamic monitoring and quantification of hormonal gene expression in single, viable pituitary cells, breast cancer cells and neurons (1, 2, 5, 19, 28, 29) . The sensitivity and temporal resolution of these new strategies depend largely on the biological properties of the reporter used to monitor gene expression; luciferase has proved to be particularly well suited for real-time imaging applications (24) .
Luciferase cDNAs from the firefly Photinus pyralis , the sea pansy Renilla reniformisand selected beetle species have been cloned and expressed inE. coli and in many eukaryotic cell types (3, 4, (15) (16) (17) 32) . The firefly luciferase gene encodes a 62-kDa monomeric protein that generates a bioluminescent signal by catalyzing the oxidation of its substrate luciferin (31) . The decay rate of the luciferase enzyme has been estimated to be approximately 3-4 h in mammalian cells (27) , which makes it suitable for detecting dynamic changes in the rate of gene expression that might evolve over the course of several hours or days. However, the capacity to detect shorter-term changes of gene expression is limited, owing to the residual photonic contribution of preexisting luciferase within the cell. The 3-4 h half-life (t 1/2 ) of firefly luciferase becomes particularly problematic in attempts to monitor a diminution of gene expression. Thus, the development of a destabilized form of luciferase would satisfy this need for a more responsive reporter protein.
Rapid turnover in proteins is often caused by signals that induce protein degradation (10, 23) . One of the best characterized of these proteolytic signals was identified as a region enriched in proline (P), glutamate (E), serine (S) and threonine (T) residues (PEST) and flanked by positively charged residues such as lysine (K), arginine (R) or histidine (H) (21, 23) . This PEST domain is composed of at least 12 hydrophilic amino acid residues and can be distributed anywhere along the polypeptide chain. Proteins may contain multiple PEST sequences that can act as constitutive or conditional proteolytic signals for intracllular degradation of key metabolic proteins (22) . The role of the PEST domain in protein degradation is supported by both mutational experiments (7) and experimental transfer of the PEST domain from mouse ornithine decarboxylase (mODC) to metabolically stable proteins (6, (12) (13) (14) . Mammalian ODC has one of the shortest t 1/2 described for animal enzymes (10-60 min) (8, 9, 23) , and attachment of the PEST degradation signal of mODC (amino acids 422-461) to the carboxyl-COOH-terminal region of the enhanced green fluorescent protein (EGFP) reporter gene decreased its t 1/2 sixfold in mammalian cells (13) . Mutation of key amino acids in the PEST domain indicated that at least one P, E, S and T was required for protein degradation. Also, protein degradation was not correlated with the number of PEST residues but with their relative position within the PEST domain (13) . Taken together, it is clear that the presence of the PEST domain within a protein can have a dramatic influence on its t 1/2 .
The goal of the present study was to construct a reporter plasmid encoding a destabilized form of firefly luciferase. This was accomplished by cloning a PEST mODC sequence variant (derived from the mODC carboxyl-COOH-terminal region) downstream of the luciferase gene. The PEST mODC-DA variant was synthetically reconstituted using PCR technology. Upon expression, this resulted in a firefly luciferase-mODC-DA/PEST hybrid protein (LUCODC-DA). The stability of this protein was evaluated in cultures of human breast cancer T-47D cells. The functionality of the LUCODC-DA variant as a reporter was demonstrated in single living cells using a photoncapture microscopic system that enabled real-time measurement of gene expression. Our results indicate that this destabilized luciferase enzyme should provide a more sensitive reporter to detect and resolve fast and transient changes in gene expression patterns in living cells.
MATERIALS AND METHODS

T-47D Cell Culture, Chemical Transfection and Microinjection
Populations of human breast carcinoma T-47D cells (HTB-133; ATCC, Manassas, VA, USA) were maintained in phenol-free RPMI 1640 medium supplemented with 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEP -ES, 1 0 000 U/mL penicillin, 10 mg/mL streptomycin, 10 µ g/mL bovine insulin and 10% fetal bovine serum (n-FBS) (Life Technologies, Rockville, MD, USA) in a 95% air/5% CO 2 environment at 37°C. Under these conditions, cells were grown as a monolayer in accordance with routine cell-culture procedures.
The T-47D cells were transfected following a chemical procedure using the L IPOFECT AMINE ™ reagent (Life Technologies) as described elsewhere (30) . Briefly, cells were plated in 6-well tissue-culture microplates (Falcon ® ; Becton Dickinson, Franklin Lakes, NJ, USA) at a concentration of 20 0 000 cells/well in phenol-free RPMI 1640 supplemented with 10% charcoalstripped FBS (cs-FBS) for 24 h before chemical transfection. An amount of 2 µ g EndoFree ™-purified plasmid DNA (Qiagen, Valencia, CA, USA) and 10 µ L L IPOFECT AMINE reagent were used for each transfection. The cells were incubated for 5 h with the DNA-L IPOFEC -T AMINE complexes at 37°C in a 5% CO 2 incubator. Following the incubation, the cells were washed with phenol/serum-free RPMI 1640 medium, covered with 2 mL fresh RPMI 1640 medium supplemented with 10% cs-FBS and 1 nM 17 β -estradiol (Sigma, St. Louis, MO, USA); they were then incubated at 37°C in the presence of 5% CO 2 for 48 h before any treatments.
Other cells were subjected to microinjection using a semiautomated micromanipulator and an injector system (both from Eppendorf, Hamburg, Germany) as described by Willard et al. (29) . In brief, culture flasks containing untransfected cells were trypsinized (0.05% trypsin, 0.53 mM EDTA; Life Technologies) to yield a suspension of monodispersed cells. Cells were then plated on alphanumeric, gridded coverslips at a concentration of 3 0 000 cells in 200 µ L RPMI 1640 supplemented with 10% n-FBS for 1 h to allow attachment. Then, 1.7 mL of the same medium were added to each well containing a coverslip. Cells on coverslips were incubated for 24 h before microinjection, with the DNA used for microinjection being purified according the EndoFree plasmid kit and diluted to a concentration of 0.4 µ g/ µ L. Following microinjection, coverslips containing T-47D cells were cultured for another 24 h before photon counting.
Molecular Cloning, PCR Amplification and DNA Sequencing
In this study, we used the E. coli strain XL1-Blue MRF ′ as the recipient for all molecular cloning procedures (Stratagene, La Jolla, CA, USA). Bacterial cultures were grown routinely in LB broth at 37°C with the addition of 50 µ g/mL ampicillin when required. Extraction and purification of plasmid DNA were performed using a plasmid purification kit (Qiagen). Restriction enzymes were used in accordance with the manufacturer's recommendations (New England Biolabs, Beverly, MA, USA). The vector pEMlux85B, used for the cloning experiments, derives from the pMAMneo-LUC (Clontech Laboratories, Palo Alto, CA, USA) (GenBank ® accession no. U02448) and contains the wild-type firefly luciferase cDNA gene fused to the estrogen response element (ERE) 5 -MMTV gene promoter (18) . This estrogenic promoter was used to drive the expression of the firefly luciferase and was induced by the addition of 17 β -estradiol. To produce the synthetic mODC PEST LUCODC-DA domain, we designed six oligonucleotides based on the DNA sequences corresponding to the 3 ′ -end of the luciferase and the mODC genes ( Figure 1 ). These oligonucleotides were synthesized and gel purified by Integrated DNA Technologies (Coralville, IA, USA). Their nucleotide sequences (with the Eco NI and Spe I sites underlined) were as follows: LUCO -
The PEST domain was reconstituted using a PCR procedure described elsewhere (26) . The oligonucleotides LUCODC-F1 and -R6INV were used as PCR primers at a concentration of 0.5 µ M.
Each of these two primers contained a unique restriction site at its 5 ′ -end ( Eco NI and Spe I) to facilitate cloning.
The oligonucleotides LUCODC-R2, -F3DA, -R4 and -F5, representing the "core sequence" of the synthetic fragment, were used at a concentration of 10 nM. (25) and inserted between the Eco NI and Spe I sites of the pEMlux85B. The recombinant DNA molecules were transformed into E. coli XL1-Blue MRF ′ , and positive clones were selected and transferred to LB-ampicillin plates.
The introduction of a Hin dIII site within the synthetic fragment allowed rapid and easy screening of positive clones. The validity of the recombinant plasmid DNA, pDA61, was determined by PCR and nucleotide DNA sequencing reactions. Automated DNA sequencing data of isolated plasmid DNA were obtained by the Biotechnology Resource Laboratory of the Medical University of South Carolina. Sequences were analyzed using the SEQED and BESTFIT programs (Genetics Computer Group, Madison, WI, USA).
Luciferase Assay Conditions
Cell extracts from transfected T-47D cells were prepared using the luciferase assay system (Promega, Madison, WI, USA). The protein concentrations of each cell extract were evaluated with the BCA protein assay reagent without modification (Pierce Chemical, Rockford, IL, USA). Generally, 20-µ L volumes of the cell lysate samples were assayed for luciferase activity in a lu - rate of protein decay, the transfected cells were treated for varying periods of time with cycloheximide (CHX), a protein synthesis inhibitor (20) , at a final concentration of 100 µ g/mL. Data from three independent experiments for each plasmid with three replicates/experiment for each period of treatment with CHX were normalized to their initial activity value. Standard deviations were calculated with Microsoft ® Excel ® version 5.0c.
Continuous Monitoring of Gene Expression in Single Living Breast Cancer Cells
Continuous measurement of luciferase enzymatic activity was conducted on T-47D cells transfected by microinjection 24 h earlier with the PEST-containing plasmid, pDA61. The imaging medium used was RPMI 1640 supplemented with 10% n-FBS and 0.1 mM luciferin. Cells were allowed to pre-incubate in this medium for 2 h at 37°C before experimentation. Then, the coverslip containing the cells was assembled in a Sykes-Moore chamber that was connected to a perifusion system (imaging medium flowed at a rate of 10 µ L/min). The combined apparatus was then placed on the heated stage of our photon-capture microscope. Photonic signals were accumulated and quantified continuously in 8-min bins for 16 h. The photon-counting imaging system is described in detail elsewhere (19) . Specific photonic emissions for individual cells were computed after subtraction of the background signal. T-47D cells transfected with pEMlux85B (squares, wild-type) or pDA61 (circles, LUCODC-DA) were treated with 100 µ M cycloheximide for various times to block protein synthesis. Cells extracts were prepared and assayed for luciferase activity as described in Materials and Methods. The values represent the mean ( ± ) the range (30 min) or ( ± ) the SD (0, 60, 90, 120, 180 and 240 min) of luciferase activity from two or three independent experiments, respectively. For each experiment, triplicate determinations were averaged for every time point. Shown in inset A is an example of an experiment using the modified luciferase enzyme (pDA61), which includes additional time points measured during the first hour. Inset B represents the calculated half-lives for the LUCODC-DA variant (white bars) and the wild-type (black bars) enzymes obtained for each of the experiments. 
RESULTS AND DISCUSSION
Generation of Synthetic PEST Sequences
To develop a destabilized luciferase enzyme, we constructed a luciferase hybrid protein containing a variant of the mODC PEST domain at its carboxyl COOH-terminal region. The PEST variant used in this study was the mODC-DA (D433A/D434A), which induced a high degree of protein degradation in mammalian CHO K1 Tet-off cells (13) . In this study, the PEST LUCODC-DA sequence variant was generated by PCR through a set of oligonucleotides spanning an artificial sequence containing the 3 ′ -end region of the mODC PEST domain (11) (sequence corresponding to amino acids 422-461) fused in frame to the 3 ′ -end region of the firefly luciferase cDNA gene (4) (Figure 1) . The resulting LUCODC-DA PCR-amplified fragment was cloned in frame downstream of the luciferase-coding sequence of the pEMlux85B vector, generating the plasmid pDA61 (LUCODC-DA).
Subsequently, the functional activity of the LUCODC-DA enzyme was evaluated at the population level in human breast cancer T-47D cells, chemically transfected with the plasmid pDA61. The results shown in Figures 2 and 3 demonstrate that the LUCODC-DA luciferase variant was active in T-47D cells, indicating that this hybrid protein was expressed and folded properly. Although this modified luciferase enzyme was active, the addition of the PEST domain (encoding 40 amino acids) was found to reduce its overall luciferase activity by approximately sevenfold compared to the unmodified enzyme (Figure 2) . A similar overall reduction in activity was observed by Li et al. 
Determination of Functional HalfLife of the LUCODC-DA Luciferase
To determine the functional t 1/2 of the LUCODC-DA variant, populations of T-47D cells were transfected with either plasmid pEMlux85B or pDA61, treated with CHX for 0-4 h with intervals of 30 min and assayed for luciferase activity. As Figure 2 shows, the degradation rate exhibited by the modified variant LUCODC-DA (t 1/2 = 0.84 h) was increased by more than fourfold compared to that of the wild-type luciferase (t 1/2 = 3.68 h). The decay rate determined for the wild-type enzyme was comparable to that published earlier (27) . Thus, the appendage of the PEST ODC-DA variant to the already short-lived luciferase enzyme destabilized it even further. This is another example that supports the role of the PEST domain as a proteolytic signal to induce protein degradation.
Analysis of LUCODC-DA Gene Expression in Single Living Human Breast Cancer T-47D Cells
Since the LUCODC-DA variant exhibited about a sevenfold reduction in overall luciferase activity, we were concerned that this destabilization might have compromised its utility as a realtime indicator of gene expression at the single-cell level. To test its functionality, we microinjected the plasmid pDA61 into individual T-47D cells and measured quantitatively the rate of photonic emissions (reflective of promoterdriven luciferase production) as described in Materials and Methods. Figure 3 shows representative examples of cells expressing the LUCODC-DA luciferase gene and exhibiting a reasonably strong and definitive signal. Figure  4 shows a more quantitative treatment of data, where promoter-driven reporter activity was monitored continuously over a 3-or 16-h period from 12 individual cells in six independent experiments. Note that gene expression in these cells was rarely constant but showed distinct short-and long-term changes consistent with our earlier observations (29) .
Together, these results demonstrate that the destabilized protein is functional in single living cells and is produced at a rate sufficient to enable unequivocal detection of reporter activity. Although other factors such as uciferase mRNA stability and processing influence the reporter activity, the availability of this shorter-lived luciferase enzyme provides a more responsive reporter system. This reporter should be useful in understanding transient dynamic changes in gene expression that occur spontaneously under basal conditions or in response to gene activating or gene-inhibiting secretagogues.
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